🔎 Trials Near Me

Domov › Akutna mieločna levkemija › Wisconsin › Madison

Klinične študije za Akutna mieločna levkemija v Madison, WI

16 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Madison in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Vključevanje udeležencevFaza 2
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • William S Middleton VA Medical Center, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Starost 18–59 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Vključevanje udeležencevFaza 3
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
6 Months – 21 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04293562

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Vključevanje udeležencevFaza 3
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Starost 1–25 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Vključevanje udeležencevFaza 1/2
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Vključevanje udeležencevFaza 3
  • University of Wisconsin, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07007312

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Vključevanje udeležencevOpazovalna študija
  • University of Wisconsin - Madison, Madison
Vse starosti · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT01351545

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

Vključevanje udeležencevFaza 1
  • University of Wisconsin Carbone Cancer Center, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 14. maj 2026 · NCT06222580

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Vključevanje udeležencevFaza 1
  • University of Wisconsin Carbone Cancer Center, Madison
Do 21 let · Vsi spoli · Posodobljeno 22. apr. 2026 · NCT05101551

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Vključevanje udeležencevFaza 1
  • University of Wisconsin Hospital and Clinics, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT05735184

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Vključevanje udeležencevFaza 1
  • University of Wisconsin Carbone Cancer Center, Madison
7 Months – 21 Years · Vsi spoli · Posodobljeno 16. okt. 2025 · NCT02508038

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Vključevanje udeležencevFaza 1
  • University of Wisconsin Clinical Science Center, Madison
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2025 · NCT06501196

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • University of Wisconsin, Madison
Starost 18–120 · Vsi spoli · Posodobljeno 25. jul. 2025 · NCT05237258

Študije za Akutna mieločna levkemija v drugih mestih

Druge študije v Madison

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.